Re-­Irradiation of Primary Brain Tumors

 

Related Videos (117)

In this video, Robert Lustig, MD, discusses the evolving concept of re-irradiation of primary brain tumors by reviewing three relevant clinical studies and a recent experience at the Roberts Proton Therapy Center at Penn Medicine. Dr. Lustig describes the studies, which involved the retreatment of glioblastomas with bevacizumab in combination with conventional fractionated, stereotactic and hypofractionated radiotherapy, with a focus on respective survival and time to progression benefits. His discussion of proton therapy examines a single case involving the retreatment of a brainstem tumor with pencil beam scanning.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®